External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

EHDN 2024

-
Coming soon
08:45 AM
Duration 12mins Strasbourg, France
The conception, birth and toddler years of the European HD Network
Patrik Brundin

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
10:30 AM
Duration 2hrs Strasbourg, France
Longitudinal relationship between the Huntington’s Disease Digital Motor Score and clinical scales
Louis-Solal Giboin

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 2hrs Strasbourg, France
Exposure dependent changes in CSF fluid biomarkers following tominersen treatment in GENERATION HD1
Yumi Yamamoto

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 2hrs Strasbourg, France
Disease progression of individuals with Huntington’s disease assessed via the HD digital motor score
Ekaterina Volkova-Volkmar

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 2hrs Strasbourg, France
Baseline clinical and imaging associations of fluid biomarkers in early manifest Huntington’s disease for the tominersen phase III trial GENERATION HD1
David Hawellek

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
06:45 AM
Duration 12mins Strasbourg, France
New fluid biomarker data from GENERATION HD1 and what it means for GENERATION HD2
Peter McColgan

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
11:00 AM
Duration 12mins Strasbourg, France
Placebo response in HD: Comparing placebo arm in GENERATION HD1 vs Enroll-HD data
Marcelo Boareto

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar